amonafide has been researched along with Benign Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, CC; Zee-Cheng, RK | 1 |
| Li, Y; Liu, J; Qian, X; Xu, Y; Yin, H | 1 |
| Chen, Y; Ding, J; He, Q; Li, XH; Miao, ZH; Wang, YQ; Xie, YY; Yang, CH | 1 |
| Huang, RZ; Jiang, H; Liang, GB; Qin, JT; Wang, HL; Wang, HS; Wei, JH; Zhang, Y | 1 |
| Li, M; Wang, C; Wang, Y; Xie, S; Zhang, J | 1 |
| Berezin, F; Janisch, L; Lane, LB; Mick, R; Ratain, MJ; Schilsky, RL; Vogelzang, NJ | 1 |
| Akerman, S; Allen, SL; Budman, DR; Calabro, A; Chan, K; Fusco, D; Hock, K; Kreis, W; Mittelman, A; Puccio, C; Spigelman, M | 1 |
| Alberts, DS; Dorr, RT; Hersh, EM; Liddil, JD; Remers, W; Sami, SM | 1 |
| Diasio, RB; Stagg, MP | 1 |
1 review(s) available for amonafide and Benign Neoplasms
| Article | Year |
|---|---|
Novel chemotherapeutic agents in early clinical development.
Topics: Adenine; Alkaloids; Anthraquinones; Antineoplastic Agents; Biphenyl Compounds; Camptothecin; Humans; Imides; Irinotecan; Isoquinolines; Naphthalimides; Neoplasms; Organophosphonates; Paclitaxel; Pyrazoles; Quinazolines; Sulfonylurea Compounds; Terpenes; Trimetrexate | 1990 |
3 trial(s) available for amonafide and Benign Neoplasms
| Article | Year |
|---|---|
Phase I study of amonafide dosing based on acetylator phenotype.
Topics: Acetylation; Adenine; Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Humans; Imides; Intercalating Agents; Isoquinolines; Lymphoma; Male; Middle Aged; Models, Biological; Naphthalimides; Neoplasms; Organophosphonates; Phenotype | 1993 |
Clinical pharmacokinetics of amonafide (NSC 308847) in 62 patients.
Topics: Adenine; Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Imides; Isoquinolines; Male; Mathematics; Metabolic Clearance Rate; Middle Aged; Models, Biological; Naphthalimides; Neoplasms; Organophosphonates; Polymorphism, Genetic | 1996 |
Novel chemotherapeutic agents in early clinical development.
Topics: Adenine; Alkaloids; Anthraquinones; Antineoplastic Agents; Biphenyl Compounds; Camptothecin; Humans; Imides; Irinotecan; Isoquinolines; Naphthalimides; Neoplasms; Organophosphonates; Paclitaxel; Pyrazoles; Quinazolines; Sulfonylurea Compounds; Terpenes; Trimetrexate | 1990 |
6 other study(ies) available for amonafide and Benign Neoplasms
| Article | Year |
|---|---|
N-(Aminoalkyl)imide antineoplastic agents. Synthesis and biological activity.
Topics: Adenocarcinoma; Animals; Chemical Phenomena; Chemistry; Colonic Neoplasms; Humans; Imides; Leukemia L1210; Leukemia P388; Melanoma; Neoplasms; Structure-Activity Relationship | 1985 |
Novel N-oxide of naphthalimides as prodrug leads against hypoxic solid tumor: synthesis and biological evaluation.
Topics: Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Naphthalimides; Neoplasms; Oxides; Prodrugs; Structure-Activity Relationship | 2007 |
Design, synthesis and biological evaluation of substituted 11H-benzo[a]carbazole-5-carboxamides as novel antitumor agents.
Topics: Amides; Animals; Antineoplastic Agents; Carbazoles; Cell Cycle Checkpoints; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Nude; Neoplasms; Structure-Activity Relationship | 2011 |
Design, synthesis and antitumor evaluation of new 1,8-naphthalimide derivatives targeting nuclear DNA.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; DNA Damage; Drug Design; Humans; Mice, Nude; Naphthalimides; Neoplasms | 2021 |
Synthesis and evaluation of novel amonafide-polyamine conjugates as anticancer agents.
Topics: Adenine; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Microscopy, Fluorescence; Naphthalimides; Neoplasms; Organophosphonates; Polyamines; Transplantation, Heterologous | 2017 |
Preclinical antitumor activity of the azonafide series of anthracene-based DNA intercalators.
Topics: Adenine; Animals; Antineoplastic Agents; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Humans; Imides; Intercalating Agents; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Naphthalimides; Neoplasms; Organophosphonates; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2001 |